Covered recipient · General Payments record
BADER AL OMOUR
General Payments · PY2021–2025
$227.16
- Reported across 11 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.61 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $39.69 | 2 |
| ABBVIE INC. | $30.14 | 1 |
| Acerta Pharma LLC | $23.20 | 1 |
| Kite Pharma, Inc. | $23.12 | 1 |
| Merck Sharp & Dohme Corporation | $21.82 | 1 |
| GlaxoSmithKline, LLC. | $19.30 | 1 |
| ARRAY BIOPHARMA INC | $19.27 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.71 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.14 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201385005 | CMS |
| ARRAY BIOPHARMA INC | $19.27 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230828623 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.20 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214771230 | CMS |
| Daiichi Sankyo Inc. | $19.00 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197065031 | CMS |
| Daiichi Sankyo Inc. | $20.69 | 09/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197026603 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.36 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184953246 | CMS |
| GlaxoSmithKline, LLC. | $19.30 | 02/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191430354 | CMS |
| Kite Pharma, Inc. | $23.12 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212087681 | CMS |
| Merck Sharp & Dohme LLC | $21.82 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238251701 | CMS |
| Novartis Pharmaceuticals Corporation | $18.71 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200064762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2025
- Source files
- Dataset page · Bulk file · PY2021 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.